Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/17/2007

insulin glargine, with reduced risk of hypoglycemia, and

weight loss instead of weight gain.

Nine months ended September 30, 2007

Total revenues for the nine months ended September 30, 2007 were $559.0 million. This includes net product sales of $506.7 million, including $459.7 million for BYETTA and $47.0 million for SYMLIN. This compares to net product sales of $323.5 million, consisting of $293.2 million for BYETTA and $30.3 million for SYMLIN for the same period in 2006.

Revenues under collaborative agreements were $52.2 million for the nine months ended September 30, 2007, compared to $24.1 million for the same period in 2006. The increase reflects $15 million in milestones associated primarily with the launch of BYETTA in the European Union during the second quarter of 2007 and higher cost-sharing payments to equalize development expenses for BYETTA and exenatide LAR.

Selling, general and administrative expenses increased to $268.6 million for the nine months ended September 30, 2007, from $192.4 million for the same period in 2006. The increase reflects higher promotional expenses for BYETTA and SYMLIN, costs associated with the Company's expanded sales force and increased business infrastructure to support the Company's growth.

Research and development expenses increased to $192.7 million for the nine months ended September 30, 2007, from $155.9 million for the same period in 2006. The increase primarily reflects costs associated with the development of exenatide LAR and costs associated with the Company's obesity programs.

Collaborative profit sharing was $212.3 million for the nine months ended September 30, 2007, compared to $130.4 million for the same period in 2006.

Net loss was $134.2 million, or $1.02 per share for the nine months ended September 30, 2007, compared to $160.4 million, or $1.33 per share, for the same period in 2006.

Conference Call

Amylin will webcast its Quarterly Update C
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...hed the Sixth Milestone in its Ofatumumab ...N, Denmark, October 10 /- G...d the sixth milestone for,ofatumumab (HuMax-CD20(R...SmithKline (GSK). A milestone payment of approxima...) was triggered by the first patient,receiving tre...
(Date:10/10/2008)...Oct. 10 /Xinhua-- Beike,Biotechnology...bal leader in,stem cell research and treatment thr...as signed eight separate mutual cooperation agreem...anding stem cell research organizations.,As part o...em Cell Expert,Advisory Committee" and a separate ...
(Date:10/10/2008)...RNewswire/ -- Twenty of Britain,s most,innovative ...bit their,ideas at the fifth annual SETsquared Par...eld at One Great George Street, London, from 8am o...m of technology innovators,in electronics, informa...Six companies will give 10-minute presentations to...
(Date:10/10/2008)...Newswire/ -- Takeda Pharmaceutical Company,Limited...earch and,Development Center, Inc., a wholly owned...ation that the U.S. Food and Drug Administration (...e alogliptin New Drug Application,(NDA) by the Pre...r 27,2008., "In our most recent discussion with ...
Breaking Biology Technology:Genmab Reaches Milestone in Ofatumumab Collaboration 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2
...sultant Tom Koulopoulos said at the Fusion2006 CE...identify information technology work they do that ... outside of the organization. As you might expect,...house raises a lot of questions, so WTN followed u...nce in IT and outsourcing. , ,This is part one of ...
Madison, Wis. Berbee Information Networks Corporation said it has been named Cisco Systems, U.S. IP communications partner of the year for 2005. , ,The award recognizes revenue growth and custom
...ht say the legacy of the 2005-2006 session of the ...y or Senate floor, but in court, where a few forme...e resources for campaigns. Others might say this L...y diet of social issues, from carrying concealed w...back the death penalty. , ,There,s a third way to...
..., Wis. The latest in a growing body of sharehold...g software developer dearly. , ,Alleging that memb...ties law, shareholders of Merge Technologies, Inc... management software, have filed several lawsuits ...Merge,s $325 million stock purchase of Cedara Corp...
Other Biology Technology:IT outsourcing according to Tom Koulopoulos, part 1 2IT outsourcing according to Tom Koulopoulos, part 1 3Four ways lawmakers could help Wisconsins high-growth economy 2Four ways lawmakers could help Wisconsins high-growth economy 3Merge's merger is the crux of shareholder lawsuits 2
(Date:10/10/2008)...tigators from the Herman B Wells Center for Pediat...edicine are focusing on a family of blood proteins...ic effects of chemotherapy in children and adults....opment of targeted therapies for leukemia, multipl...researchers, led by Kristin T. Chun, Ph.D., assist...
(Date:10/10/2008)...the 1950s, Austrian and Swiss scientists conducted...taking photographs of the glaciers, mountains and ...ist Fritz Mller spent eight months in the region a...raphing the Himalayan glaciers. , Now, fifty yea... these scientists are of immense value in trying t...
(Date:10/10/2008)...may make us all go a little gooey, but it,s not tu...health researchers at The Australian National Univ... Mental Health Research (CMHR) at ANU suggests th...ffects their cognitive functions, there is no evid...en released as part of Mental Health Week, which r...
(Date:10/9/2008)... conventional wisdom, tropical plant and animal sp...h may be threatened by global warming, according t...t Robert K. Colwell and colleagues in this week,s ...h,s climate has warmed in recent decades, the geog...nd plant species in the US and Europe have moved n...
Breaking Biology News(10 mins):On the trail of a targeted therapy for blood cancers 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Pregnancy not turning minds to mush: Study 2Tropical rainforest and mountain species may be threatened by global warming 2Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 1Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 2Emmy 28R 29 and Golden Globe 28R 29 Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hil 2663 3Mayo Clinic Proceedings January Tip Sheet 1228 1Mayo Clinic Proceedings January Tip Sheet 1228 2Mayo Clinic Proceedings January Tip Sheet 1228 3Molecule May Trigger Psoriasis 9780 1Case researcher in RNA biology makes waves by challenging current thinking 1964 1Case researcher in RNA biology makes waves by challenging current thinking 1964 2
... increasing among the general population in Canada...First Nations, Inuit and Métis children. In a stud...blic Health, University of Alberta researchers fou...northern Quebec communities were overweight or obe... at the University of Alberta, and her colleagues ...
... oldest questions in human physiology, researchers...hy the body,s immune system - perpetually on guard...ttack tissues in the small intestine that harbor m...ruary issue of Nature Immunology, and which is cur...dvanced online publication, investigators led by S...
...ext Generation," Geordi La Forge is a blind charac...implants in his eyes. While the Star Trek characte...e 21st century may not have to wait that long for ...m, a University of Missouri-Columbia veterinary op...mplant to help blind animals "see." According to N...
...ity researchers have discovered men with an unusua... than men the same age who are cognitively normal....A), a neurological disease in which people have tr...eople lose the ability to express themselves and u...r,s disease in which a person,s memory becomes imp...
Other Biology News:Why doesn't the immune system attack the small intestine? 2MU researcher placing eye implants in cats to help humans see 2Vasectomy may put men at risk for type of dementia 2Vasectomy may put men at risk for type of dementia 3
... is the first higher plant to be fully sequenced a...nism for gene expression research in higher plants...he ATH1 v.5 database of The Institute for Genomic ...base at the University of Delaware. Nearly 40,000 ...
... is in solution or in a gel piece, we can identify...s will be digested to produce a mixture of peptide...e determined by MALDI-TOF, and the amino acid sequ...F will be determined by MALDI-TOF/TOF. The masses ...
...interferons are cytopathic effect inhibition assay... types include; tissue culture supernatents; serum...ese assays, one unit is defined as the quantity of...cytopathic effect of viral infection by 50%. All...
supplied with 10x reaction buffer
Biology Products: